This event has passed.
Webinar ‘Trends in peptides and oligonucleotides – choosing a partner CDMO’
This event has passed.
Webinar ‘Trends in peptides and oligonucleotides – choosing a partner CDMO’
Register now
about the Event
Peptide and oligonucleotide drugs are versatile therapeutics with a growing range of applications and many similarities in terms and of manufacturing and regulation. New formulations often increase the complexity of the products and demand innovative solutions. Partnering with an experienced CDMO can support drug developers’ manufacturing needs and allow them to focus on the core of their developments.
Speakers
Tycho Leifels, Ph.D.
Group Leader Product Management at Bachem
Tycho Leifels is an experienced life science portfolio professional with a successful record of leading business development and pipeline strategy. His broad expertise is based on 17 years in various commercial roles with increasing responsibilities in the life science industry including successful international product launches and managing the portfolio towards higher profitability. He holds a PhD in chemistry from the University of Basel.
Naoki Yamamoto, Ph.D.
Head of Business Development & Sales, Asia Pacific at Bachem Japan
Naoki Yamamoto is Head of Business Development & Sales, Asia Pacific at Bachem Japan since Jan 2022. For the past 16 years, he’s been involved in the development of new synthetic methodologies for glycopeptides and glycoproteins, purification & analytical technologies for those materials, and coordinating several collaborations and alliances with not only domestic pharma companies but also international pharms. Prior to joining Bachem Japan, he was RAQA & BD Director at 3-D Matrix (2017-2021), and a regional president at Brand Institute (2015-2016). Prior to Brand Institute, he was served as a Senior Investigator at GlyTech (2012-2014) and American Peptide Company, Sunnyvale, California in the US (2009-2012). Prior to American Peptide Company, he was a Researcher at Otsuka Chemical Company (2006-2009). He received his Ph.D. degree in Chemistry from Yokohama City University, Japan in 2006.